Perrigo reported $2.15B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 508.97B 46.71B Nov/2026
Abbott USD 171.01B 12.96B Sep/2026
Bayer EUR 52.42B 5.31B Nov/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Coherus Biosciences USD 172M 19M Dec/2025
Corcept Therapeutics USD 7.63B 4.83B Nov/2026
Dr.Reddys Laboratories INR 1.03T 103.26B Sep/2026
Eli Lilly USD 1.09T 40.33B Sep/2026
J&J USD 653.61B 42.25B Sep/2026
Merck USD 375.59B 17.09B Nov/2026
Nestle CHF 214.06B 11.18B Jun/2026
Pacira USD 1.7B 696M Nov/2026
Perrigo USD 2.17B 31M Nov/2026
Pfizer USD 165.12B 1.71B Nov/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.2B 38M Nov/2026
Reckitt Benckiser GBP 38.8B 5.14B Dec/2025
Sanofi EUR 100.56B 13.53B Nov/2026
Supernus Pharmaceuticals USD 2.51B 193M Sep/2026
Teva Pharmaceutical Industries USD 153.58B 106.85B Nov/2026
Xeris Pharmaceuticals USD 1.44B 70M Nov/2026
Zoetis USD 37.6B 8.74B Nov/2026